TriCert Investment Counsel Inc.’s Novartis NVS Stock Holding History

TriCert Investment Counsel Inc.’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.5M	Buy	+226,301	New	+$33.9M	3.3%	6

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NewEdge Wealth Pittsburgh, Pennsylvania $10B AUM 30.45% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

AGF Management Toronto, Ontario, Canada $25.8B AUM 56.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TriCert Investment Counsel Inc.'s NVS Position: Q2 2026 in Review

TriCert Investment Counsel Inc. opened a new position in Novartis (NVS) in Q2 2026: 226,301 shares worth $35.5M. The stake represents 3.3% of the portfolio and ranks #6 among its holdings.

1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

TriCert Investment Counsel Inc. held 226,301 shares of Novartis worth $35.5M as of Q2 2026.
Novartis was a new TriCert Investment Counsel Inc. position in Q2 2026.
Novartis made up 3.3% of TriCert Investment Counsel Inc.'s portfolio in Q2 2026, its #6 holding.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on TriCert Investment Counsel Inc.'s 13F filing for Q2 2026, filed 10 Aug 2026.